Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Operating activities
Net increase (decrease) in net assets resulting from operations	$ 15,920,731	$ 11,617,485
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:
Net realized (gain) loss	177,456	1,811
Change in net unrealized (appreciation) depreciation of investments	(7,412)	(2,837,191)
Net amortization of investment discounts and premiums	(2,030,994)	(1,363,492)
Interest and dividend income paid in kind	(863,984)	(279,515)
Amortization of deferred debt issuance costs	160,981	94,278
Changes in assets and liabilities:
Purchase of investments	(167,064,372)	(68,123,549)
Proceeds from disposition of investments	55,163,465	31,086,458
Decrease (increase) in interest, dividends and fees receivable	(1,217,763)	(585,204)
Decrease (increase) in receivable for investments sold	(4,447,779)	(1,099,100)
Decrease (increase) in prepaid expenses and other assets	(632,648)	39,071
Increase (decrease) in interest and debt related payables	492,842	270,050
Increase (decrease) in incentive fees payable	1,246,143	0
Increase (decrease) in management fees payable	337,133	0
Increase (decrease) in reimbursements due to the Investment Adviser	208,415	60,109
Increase (decrease) in payable for investments purchased	(3,716,959)	(6,983,566)
Increase (decrease) in accrued expenses and other liabilities	(357,142)	720,952
Net cash provided by (used in) operating activities	(106,631,887)	(37,381,403)
Financing activities
Proceeds from common shares sold	88,562,273	26,985,992
Contribution received in advance	0	4,574,394
Draws on credit facilities	55,000,000	40,000,000
Repayments of credit facility draws	(44,000,000)	(36,000,000)
Payments of debt issuance costs	(1,222,950)	(19,253)
Dividends paid in cash to shareholders	(3,745,928)	(459,654)
Payments of repurchased shares	(588,036)	0
Net cash provided by (used in) financing activities	94,005,359	35,081,479
Net increase (decrease) in cash and cash equivalents (including restricted cash)	(12,626,528)	(2,299,924)
Cash and cash equivalents (including restricted cash) at beginning of period	20,393,858	17,633,729
Cash and cash equivalents (including restricted cash) at end of period	7,767,330	15,333,805
Supplemental cash flow information
Interest payments	6,146,265	3,020,273
Excise tax payments	73,753	18,395
Distribution payable	3,246,951	1,379,449
Reinvestment of dividends during the period	$ 13,098,484	$ 6,709,771